Alterity Therapeutics: Receives $640k grant from Michael J. Fox Foundation

  • Alterity Therapeutics (ATH) has received a US$495,000 (around A$640,428) grant from The Michael J. Fox Foundation for Parkinson’s Research
  • The grant allows Alterity to determine the optimal dosing of ATH434 in patients with the disease
  • Parkinson’s occurs when the brain cells that make dopamine degenerate and die
  • People with Parkinson’s often experience tremors, dementia, dizziness and depression
  • The company hopes clinical trials will determine the safety and tolerability of the product
  • Alterity is up a healthy 18 per cent on the back of this news with shares trading at 4.6 cents
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Experian Launches Credit Score App in ChatGPT, Enhancing Financial Access

New tool enables users to check credit scores effortlessly via ChatGPT.Highlights: Experian's app allows users to check credit...

US Senate Passes Bill Banning Issuance of CBDCs

Legislation aims to restrict the development of digital currencies by the Federal Reserve.Highlights: The US Senate approved a...

Truist Expands Open Banking Offerings with Plaid Partnership

Collaboration aims to enhance customer access to financial services.Highlights: Truist collaborates with Plaid for open banking expansion.The partnership...

UK’s National Fraud Database Reports 444,000 Fraud Cases in 2025

Cifas reveals a significant rise in reported fraud incidents across the UK.Highlights: Cifas reported 444,000 fraud cases in...